Seppic, an Air Liquide Healthcare company, announces the inauguration of its first production site in the United States. This manufacturing plant is Seppic’s second largest for the production of high performance specialty ingredients for the beauty personal care and pharmaceutical markets.
This new plant, which is already in operation, gives Seppic more than 50% additional production capacity for thickening and texturizing agents, in order to meet the growing requirements of its customers in the US and worldwide.
Located near Richmond in Virginia, the site was strategically selected for its skilled workforce, and will stimulate the local community with the creation of more than 50 jobs. The site is also ideally located to service the northeastern United States, where 80% of Seppic’s US customers are located, and to export globally.
The facility has been designed to abide by the highest levels of quality in compliance with Good Manufacturing Practices (GMP), and has already obtained ISO 9001, EFfCI and RSPO certifications. The facility currently operates fully automated units to allow for a consistent and easily traceable quality for our ingredients. Thanks to those cutting-edge technologies and by recycling 95% of its waste, Seppic minimizes its impact on the environment.
Specialty ingredients for personal beauty care represent a market of more than $10 billion worldwide, 25% of which is in the United States.
Jean-Baptiste Dellon, CEO of Seppic, said: “With this new plant, we increase our industrial capacity and our ability to serve our customers in the US and all over the world. This cutting-edge plant is in compliance with Seppic’s strategy to produce high performance ingredients while respecting the environment. Our ambition in terms of CSR is to continue to meet our customers needs while achieving an objective of reducing our waste and energy consumption.”